By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


SEARCH JOBS








Company News
RXi Pharmaceuticals (RXII) Receives Orphan Drug Designation For Samcyprone From The U.S. FDA For The Treatment Of Malignant Melanoma Stage IIb to IV 4/17/2015 6:18:05 AM
RXi Pharmaceuticals (RXII) Reports Fourth Quarter And Year End 2014 Financial Results And Recent Corporate Highlights 3/30/2015 1:04:40 PM
RXi Pharmaceuticals (RXII) And Mirimmune LLC Enter Into An Exclusive Licensing Agreement For RXi's Self-Delivering RNAi (sd-rxRNA) Technology To Develop Cell-Based Immunotherapies To Treat Cancer 3/27/2015 7:14:35 AM
RXi Pharmaceuticals (RXII) Reports Positive Advancements In Its Dermatology Programs At The Occasion Of The 73rd Annual Meeting Of The American Academy of Dermatology 3/23/2015 8:59:10 AM
RXi Pharmaceuticals (RXII) To Webcast Fourth Quarter And Year End 2014 Financial Results On Monday, March 30, 2015 3/16/2015 9:40:59 AM
RXi Pharmaceuticals (RXII) To Present At The 73rd Annual Meeting Of The American Academy of Dermatology 3/11/2015 9:47:12 AM
RXi Pharmaceuticals (RXII) Announces Closing Of The Exclusive Global Licensing Agreement To Samcyprone™ With Hapten Pharmaceuticals 2/5/2015 8:34:15 AM
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio For Ocular Indications 2/3/2015 10:56:50 AM
RXi Pharmaceuticals (RXII) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/2/2015 11:44:29 AM
RXi Pharmaceuticals (RXII) To Present At The 7th Annual Biotech Showcase™ 1/5/2015 8:17:48 AM
12345678910...
//-->